The observed loss of MLH1/PMS2 expression aligns with previous evidence showing that sporadic MLH1 promoter hypermethylation represents the most frequent cause of MMR deficiency in endometrial neoplasia. The gene discussed is PMS2; the disease is mismatch repair cancer syndrome 1.